IRTC iRhythm Technologies Inc

Price (delayed)

$65.79

Market cap

$1.93B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.04

Enterprise value

$1.92B

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
IRTC's equity has surged by 160% year-on-year
The revenue has grown by 34% YoY and by 11% from the previous quarter
The quick ratio has soared by 50% YoY but it has contracted by 20% from the previous quarter
The gross margin has contracted by 3.8% YoY

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
29.4M
Market cap
$1.93B
Enterprise value
$1.92B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.29
Price to sales (P/S)
6.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.26
Earnings
Revenue
$306.34M
EBIT
-$57.77M
EBITDA
-$43.63M
Free cash flow
-$41.72M
Per share
EPS
-$2.04
Free cash flow per share
-$1.42
Book value per share
$10.46
Revenue per share
$10.45
TBVPS
$16.52
Balance sheet
Total assets
$485.22M
Total liabilities
$178.78M
Debt
$122.47M
Equity
$306.44M
Working capital
$262.55M
Liquidity
Debt to equity
0.4
Current ratio
4.6
Quick ratio
4.37
Net debt/EBITDA
0.38
Margins
EBITDA margin
-14.2%
Gross margin
71.2%
Net margin
-19.4%
Operating margin
-19.2%
Efficiency
Return on assets
-12.1%
Return on equity
-18.4%
Return on invested capital
-13.2%
Return on capital employed
-14%
Return on sales
-18.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
6.23%
1 week
36.72%
1 month
50.79%
1 year
-71.1%
YTD
-72.27%
QTD
-0.84%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$306.34M
Gross profit
$218.16M
Operating income
-$58.8M
Net income
-$59.47M
Gross margin
71.2%
Net margin
-19.4%
The revenue has grown by 34% YoY and by 11% from the previous quarter
IRTC's operating margin is up by 33% YoY and by 15% from the previous quarter
The net margin is up by 32% YoY and by 15% from the previous quarter
The company's gross profit rose by 29% YoY and by 10% QoQ

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
6.29
P/S
6.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.26
The EPS has increased by 17% YoY and by 7% from the previous quarter
IRTC's equity has surged by 160% year-on-year
IRTC's P/B is 69% below its 5-year quarterly average of 20.0 and 57% below its last 4 quarters average of 14.7
The P/S is 66% below the last 4 quarters average of 18.3 and 51% below the 5-year quarterly average of 12.9
The revenue has grown by 34% YoY and by 11% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has soared by 63% YoY and by 19% from the previous quarter
The ROA has grown by 45% YoY and by 15% from the previous quarter
IRTC's return on invested capital is up by 32% year-on-year and by 11% since the previous quarter
The ROS has increased by 32% YoY and by 14% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 171% greater than its total liabilities
IRTC's total assets has surged by 76% year-on-year
The quick ratio has soared by 50% YoY but it has contracted by 20% from the previous quarter
The debt is 60% less than the equity
IRTC's equity has surged by 160% year-on-year
The debt to equity has plunged by 63% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.